Nutraceuticals and metastasis development

4Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Nutrigenomics is a discipline that studies the effects of various dietary components on gene expression and molecular mechanisms via "omics" technologies. Many studies are focused on revealing the pathways of the anticancer properties of various nutraceuticals. However, it has been shown that metastasis, a multifactorial disease that develops from primary tumors in cascades, is responsible for almost 90% of cancer deaths. Regrettably, the effects of consumption of different nutraceuticals on metastasis development have not yet been sufficiently explored. A few studies on the subject have revealed the promotional effects of some nutraceuticals on metastasis development. Additionally, it has been shown that certain compounds can have beneficial effects on reduction of the primary tumor, but afterwards promote the spread of metastases. Therefore, in this review we discuss results published in the past five years focused on the effects of different nutraceuticals on metastasis development.

Cite

CITATION STYLE

APA

Martinović, L. S., Peršurić, Ž., & Pavelić, K. (2020, May 1). Nutraceuticals and metastasis development. Molecules. MDPI AG. https://doi.org/10.3390/molecules25092222

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free